28-09-2026 20:14 via medpagetoday.com

Parkinson's Disease Gets New Treatment Approved

(MedPage Today) -- The FDA approved the dopamine agonist tavapadon (Juvmo) to treat adults with Parkinson's disease, drugmaker AbbVie announced Monday.
Tavapadon is an oral selective D1/D5 dopamine agonist that was studied as monotherapy for early...
Read more »

Medical Industry news



Boot Camp Promises a Submitted Paper in Just 2 Days
Unexpected Cognitive Improvement Emerges in Hearing Aid Trial
Still in Pain After ACL Repair? Supervised Rehab Superior to Exercises Alone
Insurance Formularies Holding Up Lower-Emission Asthma, COPD Inhalers
Two Symptoms Linked to Antibiotic Delays in Presumed Sepsis
More Medical Testing, More Problems
Few Lab Tests Actually Need 8 Hours of Fasting, Study Suggests
Twin Doctors Lead Hometown Emergency Department
Risk of AMD Progression After Cataract Surgery
First New Drug Approved for Idiopathic Nephrotic Syndrome in 70 Years
Trump Uses Rare Authority to Cancel Nearly $1B in HHS Programs Approved by Congress
She Developed a Rare Eye Disease After a Strep Infection
One Shot or Two? What to Know About HPV Vaccination Recommendations
3,901 Dead in Outbreak; 8 Hospitalized After Cheese Consumption; New FDA Approvals
Desktop versie